Novartis AG (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 103   

Articles published

NVS 88.41 -0.72 (-0.81%)
price chart
Novartis AG (ADR) (NYSE:NVS) Loses, Ranbaxy Laboratories Ltd. Benefits!
Ranbaxy Laboratories Limited, a pharmaceutical company who was facing the quality control problems has finally received some good news.
Ranbaxy Gets FDA Nod For New Generic Blood-Pressure Drug  ValueWalk
Related articles »  
Trending Stocks: Novartis AG (ADR) (NYSE:NVS), Yum! Brands, Inc. (NYSE ...
Swiss pharmaceutical giant Novartis AG (NYSE:NVS) Thursday said its second-quarter profit improved slightly from the prior year, amid a small growth in sales.
Trending Stocks: Yahoo Inc. (NASDAQ:YHOO), eBay Inc (NASDAQ:EBAY ...  Markets Insider
Stock Alert: Nokia Corporation (ADR) (NYSE:NOK), Microsoft Corporation ...  Crazy Joys
Related articles »  
Notable Movers: Novartis AG (ADR) (NYSE:NVS), Pfizer Inc. (NYSE:PFE), Abbott ...
Novartis AG (NYSE:NVS) announced that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients ...
Notable Stocks: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA ...  Crazy Joys
Related articles »  
Stocks Roundup - Novartis AG (ADR)(NYSE:NVS), MELA Sciences Inc ...
Las Vegas, NV - July 5, 2014 - (TechSonian) ´┐ŻNovartis AG (ADR)( NYSE:NVS) offers patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, ...
Notable Stocks: Merck (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), Novartis ...
Novartis AG (ADR) (NYSE:NVS) announced that it has begun shipment of its seasonal influenza vaccines to customers in the US market for the 2014-2015 season.
Related articles »  
Hot Movers: Red Hat Inc. (NYSE:RHT), Novartis (NYSE:NVS), Abbott ...
Tokyo prosecutors charged Novartis AG (ADR) (NYSE:NVS) Pharma K.K. and a former employee Tuesday with causing a medical research team to release data manipulated in favor of the firm's drug for treating high blood pressure in 2011.
Related articles »  
Notable Movers: AstraZeneca plc (ADR) (NYSE:AZN), Intercept Pharmaceuticals ...
Novartis AG (ADR) (NYSE:NVS) net profit margin is 16.50% and weekly performance is -1.84%. On last trading day company shares ended up $89.81.
Roches 1H14 Earnings amp; Revenues Up Y/Y, Outlook Reaffirmed
Roche's (RHHBY - Analyst Report) core earnings came in at $1.06 per American Depositary Receipt (ADR) in the first half of 2014 compared with $1.01 per ADR reported in the year-ago period. Roche's revenues in the first half of 2014 grew 3.2% from the ...
Roche's 1H14 Earnings & Revenues Up Y/Y, Outlook Reaffirmed  Yahoo News
Related articles »  
GlaxoSmithKline plc trims 2014 forecast
Unveiling its second quarter results, GlaxoSmithKline plc (ADR) (NYSE:GSK) (LON:GSK) said 2014 earnings per share looked set to be broadly similar to last year, compared with its previous forecast for growth of 4-8%.
News In Considerations: Novartis (NYSE:NVS), Raytheon ( NYSE:RTN), Textron ...
Novartis AG (ADR) (NYSE:NVS) [Trend Analysis] reported a collaboration with Banner Alzheimer's Institute on a pioneering clinical study in Alzheimer's disease prevention.